Systems Medicine: The Application of Systems Biology Approaches for Modern Medical Research and Drug Development

The exponential development of highly advanced scientific and medical research technologies throughout the past 30 years has arrived to the point where the high number of characterized molecular agents related to pathogenesis cannot be readily integrated or processed by conventional analytical approaches. Indeed, the realization that several moieties are signatures of disease has partly led to the increment of complex diseases being characterized. Scientists and clinicians can now investigate and analyse any individual dysregulations occurring within the genomic, transcriptomic, miRnomic, proteomic, and metabolomic levels thanks to currently available advanced technologies. However, there are drawbacks within this scientific brave new age in that only isolated molecular levels are individually investigated for their influence in affecting any particular health condition. Since their conception in 1992, systems biology/medicine focuses mainly on the perturbations of overall pathway kinetics for the consequent onset and/or deterioration of the investigated condition/s. Systems medicine approaches can therefore be employed for shedding light in multiple research scenarios, ultimately leading to the practical result of uncovering novel dynamic interaction networks that are critical for influencing the course of medical conditions. Consequently, systems medicine also serves to identify clinically important molecular targets for diagnostic and therapeutic measures against such a condition.

[1]  M. Mesarovic,et al.  Search for organising principles: understanding in systems biology. , 2004, Systems biology.

[2]  Daniel L Rubin,et al.  Content-based image retrieval in radiology: analysis of variability in human perception of similarity , 2015, Journal of medical imaging.

[3]  Michael J. Bolt,et al.  Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity , 2014, Oncogene.

[4]  A. Mukherjee,et al.  A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer. , 2011, The Analyst.

[5]  J. Ruíz-Cabello,et al.  Systems medicine: a new approach to clinical practice. , 2014, Archivos de bronconeumologia.

[6]  F. Bruggeman,et al.  The nature of systems biology. , 2007, Trends in microbiology.

[7]  K. Basso,et al.  A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas , 2008, Molecular systems biology.

[8]  T. Tillmann,et al.  Systems Medicine 2.0: Potential Benefits of Combining Electronic Health Care Records With Systems Science Models , 2015, Journal of medical Internet research.

[9]  Marcos J Araúzo-Bravo,et al.  Computational Biology Methods for Characterization of Pluripotent Cells. , 2016, Methods in molecular biology.

[10]  F. Lang,et al.  Up-Regulation of hERG K+ Channels by B-RAF , 2014, PloS one.

[11]  Ina Koch,et al.  MONALISA for stochastic simulations of Petri net models of biochemical systems , 2015, BMC Bioinformatics.

[12]  Alex Yang,et al.  Hyperscape: visualization for complex biological networks , 2015, Bioinform..

[13]  Nathalie Meurice,et al.  Softening the Rule of Five--where to draw the line? , 2012, Bioorganic & medicinal chemistry.

[14]  Douglas B Kell,et al.  The virtual human: Towards a global systems biology of multiscale, distributed biochemical network models , 2007, IUBMB life.

[15]  Assia Benabdallah,et al.  Mathematical and numerical analysis for a model of growing metastatic tumors. , 2009, Mathematical biosciences.

[16]  Fabian J. Theis,et al.  Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems , 2015, Bioinform..

[17]  H. Westerhoff,et al.  Understanding Dupuytren's Disease Using Systems Biology: A Move Away from Reductionism , 2012, Front. Physio..

[18]  Joshua C Denny,et al.  Using systems approaches to address challenges for clinical implementation of pharmacogenomics , 2014, Wiley interdisciplinary reviews. Systems biology and medicine.

[19]  Kerstin Hünniger,et al.  Bottom-up modeling approach for the quantitative estimation of parameters in pathogen-host interactions , 2015, Front. Microbiol..

[20]  Wei Fan,et al.  miRNA-mRNA Correlation-Network Modules in Human Prostate Cancer and the Differences between Primary and Metastatic Tumor Subtypes , 2012, PloS one.

[21]  Jun Zou,et al.  Advanced Systems Biology Methods in Drug Discovery and Translational Biomedicine , 2013, BioMed research international.

[22]  R. Donn,et al.  Network analysis: a new approach to study endocrine disorders. , 2013, Journal of molecular endocrinology.

[23]  M. Shokrgozar,et al.  Reconstruction and validation of a constraint‐based metabolic network model for bone marrow‐derived mesenchymal stem cells , 2015, Cell proliferation.

[24]  Óttar Rolfsson,et al.  Decoding the jargon of bottom‐up metabolic systems biology , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  Eric A Sobie,et al.  An Introduction to Dynamical Systems , 2011, Science Signaling.

[26]  Ben van Ommen,et al.  Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology , 2009, PLoS Comput. Biol..

[27]  J. Costa,et al.  Systems medicine in oncology , 2008, Nature Clinical Practice Oncology.

[28]  Tero Aittokallio,et al.  Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles , 2014, Current pharmaceutical design.

[29]  Mariana Benítez,et al.  Development of cell differentiation in the transition to multicellularity: a dynamical modeling approach , 2015, Front. Microbiol..

[30]  A. Tozeren,et al.  Sequence- and Interactome-Based Prediction of Viral Protein Hotspots Targeting Host Proteins: A Case Study for HIV Nef , 2011, PloS one.

[31]  E. Schadt,et al.  Unifying immunology with informatics and multiscale biology , 2014, Nature Immunology.

[32]  Aman Chandra Kaushik,et al.  Boolean network model for GPR142 against Type 2 diabetes and relative dynamic change ratio analysis using systems and biological circuits approach , 2015, Systems and Synthetic Biology.

[33]  Metabolite profiling reveals new insights into the regulation of serum urate in humans , 2013, Metabolomics.

[34]  Harrison C Schramm,et al.  Differential equation models for sharp threshold dynamics. , 2014, Mathematical biosciences.

[35]  Ines Thiele,et al.  Applying systems biology methods to the study of human physiology in extreme environments , 2013, Extreme Physiology & Medicine.

[36]  Filip Pattyn,et al.  The microRNA body map: dissecting microRNA function through integrative genomics , 2011, Nucleic acids research.

[37]  Ravi Iyengar,et al.  Systems Pharmacology of Adverse Event Mitigation by Drug Combinations , 2013, Science Translational Medicine.

[38]  J. Ruíz-Cabello,et al.  Systems medicine: A new approach to clinical practice☆ , 2014 .

[39]  P. Cardinal-Fernández,et al.  Medicina de sistemas: una nueva visión de la práctica clínica , 2014 .

[40]  H. Westerhoff,et al.  Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[41]  E. Clercq.  Frontiers in Microbiology , 1987, New Perspectives in Clinical Microbiology.

[42]  N. Navin.  Delineating cancer evolution with single-cell sequencing , 2015, Science Translational Medicine.

[43]  D. Kell,et al.  The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. , 2013, Drug discovery today.

[44]  Peter D. Karp,et al.  Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology , 2015, Briefings Bioinform..

[45]  D. Kell,et al.  Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it , 2013, The FEBS journal.

[46]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.

[47]  Alvis Brazma,et al.  Minimum Information About a Microarray Experiment (MIAME) – Successes, Failures, Challenges , 2009, TheScientificWorldJournal.

[48]  R. Goodacre,et al.  Dupuytren's: a systems biology disease , 2011, Arthritis research & therapy.

[49]  Sarah J. Wheelan,et al.  Integrated Analysis of Drug-Induced Gene Expression Profiles Predicts Novel hERG Inhibitors , 2013, PloS one.

[50]  Chang Liu,et al.  Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..

[51]  Stephen T. C. Wong,et al.  Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. , 2014, Drug discovery today.

[52]  T Kamada.  System biomedicine: a new paradigm in biomedical engineering. , 1992, Frontiers of medical and biological engineering : the international journal of the Japan Society of Medical Electronics and Biological Engineering.

[53]  Stephen T. C. Wong,et al.  A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. , 2012, Cancer research.

[54]  Gerold Baier,et al.  Systems biology and modeling in neuroblastoma: practicalities and perspectives , 2010, Expert review of molecular diagnostics.

[55]  Toshihiro Endo,et al.  Application of NeuroTrace staining in the fresh frozen brain samples to laser microdissection combined with quantitative RT-PCR analysis , 2015, BMC Research Notes.

[56]  Chris F. Taylor,et al.  RDML: structured language and reporting guidelines for real-time quantitative PCR data , 2009, Nucleic acids research.

[57]  Dianjing Guo,et al.  A new multiple regression approach for the construction of genetic regulatory networks , 2010, Artif. Intell. Medicine.

[58]  Monika Heiner,et al.  A structured approach for the engineering of biochemical network models, illustrated for signalling pathways , 2008, Briefings Bioinform..

[59]  Stephen T. C. Wong,et al.  DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies , 2013, Bioinform..

[60]  Alain Friboulet,et al.  Systems Biology-an interdisciplinary approach. , 2005, Biosensors & bioelectronics.

[61]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[62]  J. Stanley,et al.  Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome. , 2008, The Journal of hand surgery.

[63]  Alessandro Giuliani,et al.  Why network approach can promote a new way of thinking in biology , 2014, Front. Genet..

[64]  Carole A. Goble,et al.  SEEK: a systems biology data and model management platform , 2015, BMC Systems Biology.

[65]  Carson M. Andorf,et al.  Predicting the Binding Patterns of Hub Proteins: A Study Using Yeast Protein Interaction Networks , 2013, PloS one.

[66]  Tunahan Çakır,et al.  Metabolic Network Discovery by Top-Down and Bottom-Up Approaches and Paths for Reconciliation , 2014, Front. Bioeng. Biotechnol..